Quashing the resistance: MicroRNA regulates drug tolerance in subset of lung cancers

(Beth Israel Deaconess Medical Center) Relapse of disease following conventional treatments remains one of the central problems in cancer management, yet few therapeutic agents targeting drug resistance and tolerance exist. New research conducted at the Cancer Center at Beth Israel Deaconess Medical Center found that a microRNA mediates drug tolerance in lung cancers with a specific mutation. The findings, published today in Nature Metabolism, suggest that the microRNA could serve as a potential target for reversing and preventing drug tolerance in a subset of non-small-cell lung cancers.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news